UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                    FORM 8-K

                                 CURRENT REPORT
     Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934

                Date of Report (Date of earliest event reported)
                                 August 16, 2002

                                  GenoMed, Inc.
             (Exact name of registrant as specified in its charter)

            Florida                       000-49720               43-1916702
(State or other jurisdiction of   (Commission File Number)      (IRS Employer
         incorporation)                                      Identification No.)

                 4560 Clayton Avenue, St. Louis, Missouri 63110
                    (Address of principal executive offices)

                                 (314) 344-1227
                           (Issuer's telephone number)

                                 Not Applicable
          (Former name or former address, if changed since last report)

                             All Correspondence to:
                          Brenda Lee Hamilton, Esquire
                         Hamilton, Lehrer & Dargan, P.A.
                          2 East Camino Real, Suite 202
                              Boca Raton, FL 33432
                                 (561) 416-8956

Item 9. Regulation FD Disclosure

On August 16,  2002,  we filed our Form 10-QSB  Quarterly  Report for the period
ended June 30, 2002 with the United States  Securities and Exchange  Commission.
In connection with the new legislation that requires our Chief Executive Officer
and Chief Financial  Officer to certify periodic reports that contain  financial
statements,  we have  attached as Exhibit 99.1 to this Form 8-K Current  Report,
the  Certification  of Jerry E. White, our President,  Chief Executive  Officer,
Chief Financial Officer, and Principal Accounting Officer.

Exhibits

99.1 Certification  Pursuant to 18 U.S.C.  Section 1350, as Adopted  Pursuant to
     Section 906 of the Sarbanes-Oxley Act of 2002.


                                   SIGNATURES

Pursuant  to the  requirements  of the  Securities  Exchange  Act of  1934,  the
registrant  has duly  caused  this  report  to be  signed  on its  behalf by the
undersigned hereunto duly authorized.

GenoMed, Inc.

/s/ Jerry E. White
- ------------------
By:  Jerry E. White
President,  Chief  Executive  Officer,  Chief Financial  Officer,  and Principal
Accounting Officer

Date: August 16, 2002